Patents by Inventor Zhuangyu Pan

Zhuangyu Pan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • B7-H3L cell surface antigen and antibodies that bind thereto
    Patent number: 9574007
    Abstract: The invention provides the identification and characterization of disease and cancer-associated antigen, RAAG10. The invention also provides a family of monoclonal antibodies that bind to antigen RAAG10, methods of diagnosing and treating various human cancers and diseases that express RAAG10.
    Type: Grant
    Filed: June 3, 2014
    Date of Patent: February 21, 2017
    Assignee: MacroGenics, Inc.
    Inventors: Jennie P. Mather, Ronghao Li, Zhuangyu Pan, Penelope E. Roberts
  • Novel B7-H3L Cell Surface Antigen and Antibodies That Bind Thereto
    Publication number: 20140328857
    Abstract: The invention provides the identification and characterization of disease and cancer-associated antigen, RAAG10. The invention also provides a family of monoclonal antibodies that bind to antigen RAAG10, methods of diagnosing and treating various human cancers and diseases that express RAAG10.
    Type: Application
    Filed: June 3, 2014
    Publication date: November 6, 2014
    Applicant: MACROGENICS WEST, INC.
    Inventors: Jennie P. Mather, Ronghao Li, Zhuangyu Pan, Penelope E. Roberts
  • B7-H3L cell surface antigen and antibodies that bind thereto
    Patent number: 8779098
    Abstract: The invention provides the identification and characterization of disease and cancer-associated antigen, RAAG10. The invention also provides a family of monoclonal antibodies that bind to antigen RAAG10, methods of diagnosing and treating various human cancers and diseases that express RAAG10.
    Type: Grant
    Filed: March 27, 2009
    Date of Patent: July 15, 2014
    Assignee: MacroGenics West, Inc.
    Inventors: Jennie P. Mather, Ronghao Li, Zhuangyu Pan, Penelope E. Roberts
  • Human fetal bladder-derived epithelial cells
    Patent number: 7846726
    Abstract: This invention discloses a substantially pure population of human urinary bladder-derived epithelial cells and methods of isolating and culturing the urinary bladder-derived epithelial cells. In addition, several uses of human urinary bladder-derived epithelial cells and cells differentiating therefrom are disclosed herein.
    Type: Grant
    Filed: February 12, 2003
    Date of Patent: December 7, 2010
    Assignee: Raven biotechnologies, inc.
    Inventors: Ronghao Li, Zhuangyu Pan
  • NOVEL RAAG10 CELL SURFACE TARGET AND A FAMILY OF ANTIBODIES RECOGNIZING THAT TARGET
    Publication number: 20090202561
    Abstract: The invention provides the identification and characterization of disease and cancer-associated antigen, RAAG10. The invention also provides a family of monoclonal antibodies that bind to antigen RAAG10, methods of diagnosing and treating various human cancers and diseases that express RAAG10.
    Type: Application
    Filed: March 27, 2009
    Publication date: August 13, 2009
    Inventors: Jennie P. MATHER, Ronghao Li, Zhuangyu Pan, Penelope E. Roberts
  • RAAG10 cell surface target and a family of antibodies recognizing that target
    Patent number: 7527969
    Abstract: The invention provides the identification and characterization of disease and cancer-associated antigen, RAAG10. The invention also provides a family of monoclonal antibodies that bind to antigen RAAG10, methods of diagnosing and treating various human cancers and diseases that express RAAG10.
    Type: Grant
    Filed: June 19, 2003
    Date of Patent: May 5, 2009
    Assignee: Raven biotechnologies, inc.
    Inventors: Jennie P. Mather, Ronghao Li, Zhuangyu Pan, Penelope E. Roberts
  • Antibodies that bind to integrin alpha-v-beta-6 and methods of use thereof
    Publication number: 20040048312
    Abstract: The invention provides monoclonal antibody mBLA3 that binds to integrin &agr;v&bgr;6 and other equivalent antibodies. The invention also provides the identification and characterization of cancer-associated antigen, integrin &agr;v&bgr;6, with various human cancers and methods of diagnosing and treating these human cancers.
    Type: Application
    Filed: April 14, 2003
    Publication date: March 11, 2004
    Inventors: Ronghao Li, Jennie P. Mather, Zhuangyu Pan
  • Novel RAAG10 cell surface target and a family of antibodies recognizing that target
    Publication number: 20040037833
    Abstract: The invention provides the identification and characterization of disease and cancer-associated antigen, RAAG10. The invention also provides a family of monoclonal antibodies that bind to antigen RAAG10, methods of diagnosing and treating various human cancers and diseases that express RAAG10.
    Type: Application
    Filed: June 19, 2003
    Publication date: February 26, 2004
    Inventors: Jennie P. Mather, Ronghao Li, Zhuangyu Pan, Penelope E. Roberts
  • Human fetal bladder-derived epithelial cells
    Publication number: 20030211090
    Abstract: This invention discloses a substantially pure population of human urinary bladder-derived epithelial cells and methods of isolating and culturing the urinary bladder-derived epithelial cells. In addition, several uses of human urinary bladder-derived epithelial cells and cells differentiating therefrom are disclosed herein.
    Type: Application
    Filed: February 12, 2003
    Publication date: November 13, 2003
    Inventors: Ronghao Li, Zhuangyu Pan